US 12187746
C26-linked rapamycin analogs as mTOR inhibitors
granted A61PA61P35/00
Quick answer
US patent 12187746 (C26-linked rapamycin analogs as mTOR inhibitors) held by Revolution Medicines, Inc. expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Revolution Medicines, Inc.
- Grant date
- Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P35/00